{ "cik": 1645469, "cik_padded": "0001645469", "entityName": "Monopar Therapeutics", "fiscal_years": [ { "accn": "0001437749-26-010025", "filed": "2026-03-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 34999957.0, "cash": 61833552.0, "net_income": -13716894.0, "operating_cash_flow": -12201291.0, "operating_income": -16704415.0, "stockholders_equity": 137827553.0, "total_assets": 140717709.0, "total_liabilities": 2890156.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.020969363070677167, "roa_avg2y": -0.13648054577516464, "roa_period_end": -0.09747809353547676, "roe_avg2y": -0.14224397457769328, "roe_period_end": -0.0995221470702596 } }, { "accn": "0001437749-26-010025", "filed": "2026-03-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cash": 45816289.0, "net_income": -15586419.0, "operating_cash_flow": -6404139.0, "operating_income": -16161721.0, "stockholders_equity": 55036771.0, "total_assets": 60291071.0, "total_liabilities": 5254300.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09546890023762476, "roa_avg2y": -0.4608896444997008, "roa_period_end": -0.2585195243919286, "roe_avg2y": -0.5141950692340957, "roe_period_end": -0.28320009907557986 } }, { "accn": "0001437749-26-010025", "filed": "2026-03-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 7266080.0, "net_income": -8402196.0, "operating_cash_flow": -7858293.0, "operating_income": -8831235.0, "stockholders_equity": 5587766.0, "total_assets": 7345159.0, "total_liabilities": 1757393.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3145072646206015, "roa_avg2y": -0.8168529892870022, "roa_period_end": -1.143909342193954, "roe_avg2y": -1.0718851790518056, "roe_period_end": -1.5036771403813258 } }, { "accn": "0001437749-25-009979", "filed": "2025-03-31", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 8186194.0, "net_income": -10515638.0, "operating_cash_flow": -7228559.0, "operating_income": -10536877.0, "stockholders_equity": 10089652.0, "total_assets": 13226954.0, "total_liabilities": 3137302.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.31094253795869276, "roa_avg2y": -0.6231753596182215, "roa_period_end": -0.7950158441618531, "roe_avg2y": -0.7244489226120893, "roe_period_end": -1.0422200884629123 } }, { "accn": "0001654954-23-003384", "filed": "2024-03-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 20303869.0, "net_income": -9103224.0, "operating_cash_flow": -7317401.0, "operating_income": -9127248.0, "stockholders_equity": 18941071.0, "total_assets": 20521614.0, "total_liabilities": 1580543.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08344528142046456, "roa_avg2y": -0.48693008938073756, "roa_period_end": -0.4435920098682297, "roe_avg2y": -0.5256955911088659, "roe_period_end": -0.48060766996755355 } }, { "accn": "0001654954-23-003384", "filed": "2023-03-23", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 16737109.0, "net_income": -6304573.0, "operating_cash_flow": -4662274.0, "operating_income": -6508875.0, "stockholders_equity": 15691991.0, "total_assets": 16868657.0, "total_liabilities": 1176666.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07498513094992217, "roa_avg2y": -0.41723570860984655, "roa_period_end": -0.37374480967868395, "roe_avg2y": -0.4452406116459598, "roe_period_end": -0.40177011317429384 } }, { "accn": "0001654954-22-003701", "filed": "2022-03-24", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 13213929.0, "net_income": -4224874.0, "operating_cash_flow": -3017680.0, "operating_income": -4323761.0, "stockholders_equity": 12627856.0, "total_assets": 13352021.0, "total_liabilities": 724165.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.057346631130415174, "roa_avg2y": -0.40879331451570144, "roa_period_end": -0.316422060750204, "roe_avg2y": -0.4322948738019447, "roe_period_end": -0.3345677999495718 } }, { "accn": "0001654954-21-003243", "filed": "2021-03-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 6892772.0, "net_income": -3227932.0, "operating_cash_flow": -2680487.0, "operating_income": -3331147.0, "stockholders_equity": 6918404.0, "total_assets": 7317955.0, "total_liabilities": 399551.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05775190347369133, "roa_avg2y": -0.37426986562060593, "roa_period_end": -0.44109754706062015, "roe_avg2y": -0.39037008783028265, "roe_period_end": -0.46657177002094696 } }, { "accn": "0001654954-20-003363", "filed": "2020-03-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 8981894.0, "net_income": -16554872.0, "operating_cash_flow": -2627468.0, "operating_income": -16603127.0, "stockholders_equity": 9619400.0, "total_assets": 9931267.0, "total_liabilities": 311867.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.032420629145268935, "roa_avg2y": -2.5812875243639644, "roa_period_end": -1.6669446103905978, "roe_avg2y": -2.6593197871628154, "roe_period_end": -1.720988003409776 } }, { "accn": "0001654954-19-002003", "filed": "2019-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 2072611.0, "net_income": -1185597.0, "operating_cash_flow": -1194632.0, "operating_income": -1192829.0, "stockholders_equity": 2831056.0, "total_assets": 2895566.0, "total_liabilities": 64510.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.022786550319032896, "roa_period_end": -0.40945259061613515, "roe_period_end": -0.4187826026754681 } } ], "latest_filing": { "accn": "0001437749-26-010025", "filed": "2026-03-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001645469.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001645469.json" }, "ticker": "MNPR" }